Form F-X Satellos Bioscience Inc. Filed by: Satellos Bioscience Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM F-X
APPOINTMENT OF AGENT FOR SERVICE OF PROCESS
AND UNDERTAKING
| A. | Name of issuer or person filing (“Filer”): |
SATELLOS BIOSCIENCE INC.
| B. | (1) | This is an (check one): |
| x | original filing for the Filer. |
| ¨ | amended filing for the Filer. |
| (2) | Check the following box if you are filing the Form F-X in paper in accordance with Regulation S-T Rule 101(b)(9): ¨ |
| C. | Identify the filing in conjunction with which this Form is being filed: |
| Name of registrant: | SATELLOS BIOSCIENCE INC. |
| Form type: | Registration Statement on Form F-10 |
| File Number (if known): | 333-293229 |
| Filed by: | SATELLOS BIOSCIENCE INC. |
| Date Filed (if filed concurrently, so indicate): | February 5, 2026 (filed concurrently) |
| D. | The Filer is incorporated or organized under the laws of: |
Canada
| and has its principal place of business at: |
200 Bay Street, Suite 2800, Toronto, Ontario M5J 2J1, Canada
(647) 660-1780
| E. | The Filer designates and appoints Satellos Bioscience US, Inc (“Agent”) located at: |
Satellos Bioscience US, Inc.
6 Liberty Square 2089
Boston, MA 02109
(647) 660-1780
as the agent of the Filer upon whom may be served any process, pleadings, subpoenas, or other papers in:
(a) any investigation or administrative proceeding conducted by the Commission; and
(b) any civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any state or of the United States or of any of its territories or possessions or of the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns any offering made or purported to be made in connection with the securities registered or qualified by the Filer on Form F-10 on the date hereof, or any purchases or sales of any security in connection therewith. The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be commenced by the service of process upon, and that service of an administrative subpoena shall be effected by service upon such agent for service of process, and that service as aforesaid shall be taken and held in all courts and administrative tribunals to be valid and binding as if personal service thereof had been made.
F. The Filer, in connection with the use of Form F-10, stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the date the issuer of the securities to which such Forms and Schedules relate has ceased reporting under the Exchange Act. The Filer further undertakes to advise the Commission promptly of any change to the Agent’s name or address during such period by amendment of this Form, referencing the file number of the Form F-10 in conjunction with which the amendment is being filed.
G. The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to the Form F-10, the securities to which the Form F-10 relates; and the transactions in such securities.
2
The Filer certifies that it has duly caused this power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereunto duly authorized, in Toronto, Ontario, Canada, on February 5, 2026.
| Filer: | SATELLOS BIOSCIENCE INC. | |
| By: | /s/ Elizabeth Williams, CPA, CA | |
| Name: Elizabeth Williams, CPA, CA | ||
| Title: Chief Financial Officer | ||
This statement has been signed by the following person in the capacity and on the date indicated.
| SATELLOS BIOSCIENCE US, INC. | ||
| (Agent for Service) | ||
| By: | /s/ Frank Gleeson, MBA | |
| Name: Frank Gleeson, MBA | ||
| Title: President and Chief Executive Officer | ||
| Date: February 5, 2026 | ||
3
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Asia-Pacific Symposium for Strategic Innovation in Sustainable Technology Convened to Promote Pragmatic Cooperation on Low-Altitude Industry in the Asia-Pacific
- Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy- Back Programme
- Hyundai Motor Group Executive Chair Euisun Chung Announces Physical AI Vision at San Francisco AI Summit
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share